BR1101125A - Imunoglobulina humanizada e composição farmacêutica - Google Patents

Imunoglobulina humanizada e composição farmacêutica

Info

Publication number
BR1101125A
BR1101125A BR1101125-4A BR1101125A BR1101125A BR 1101125 A BR1101125 A BR 1101125A BR 1101125 A BR1101125 A BR 1101125A BR 1101125 A BR1101125 A BR 1101125A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
humanized immunoglobulin
humanized
immunoglobulin
pharmaceutical
Prior art date
Application number
BR1101125-4A
Other languages
English (en)
Inventor
Cary L Queen
Harold E Selick
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to BR1101125-4A priority Critical patent/BR1101125A/pt
Publication of BR1101125A publication Critical patent/BR1101125A/pt

Links

BR1101125-4A 1997-05-14 1997-05-14 Imunoglobulina humanizada e composição farmacêutica BR1101125A (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR1101125-4A BR1101125A (pt) 1997-05-14 1997-05-14 Imunoglobulina humanizada e composição farmacêutica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR1101125-4A BR1101125A (pt) 1997-05-14 1997-05-14 Imunoglobulina humanizada e composição farmacêutica

Publications (1)

Publication Number Publication Date
BR1101125A true BR1101125A (pt) 2003-01-14

Family

ID=3949086

Family Applications (1)

Application Number Title Priority Date Filing Date
BR1101125-4A BR1101125A (pt) 1997-05-14 1997-05-14 Imunoglobulina humanizada e composição farmacêutica

Country Status (1)

Country Link
BR (1) BR1101125A (pt)

Similar Documents

Publication Publication Date Title
BR9504791B1 (pt) composto de polipeptìdeo e composição farmacêutica.
NO955167D0 (no) Monoklonalt anti-
DK1516629T3 (da) Humaniseret anti-CD-11a antibodies
DE69531318D1 (de) Shampoozusammensetzung
NO20021172L (no) Farmasöytisk sammensetning
BR9406411A (pt) Composição de xampu
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
BR9607058A (pt) Composição
BR9710577A (pt) Composi-Æo de xampu
BR9606809A (pt) Composição inseticidamente ativa
PT728814E (pt) Composicao betuminosa
BR9509688A (pt) Composto e composição farmacêutica
LV11727A (lv) Farmaceitiska kompozicija
BR9609903A (pt) ComposiçÃo inseticidamente ativa
BR9507768A (pt) Composição farmacêutica
DE69616374D1 (de) Germizide zusammensetzung
BR9605972A (pt) Composição de xampu
FI973280A0 (fi) Farmaseuttinen koostumus
DE69413111D1 (de) Shampoozusammensetzung
BR9607946A (pt) Composição
DE69603749T2 (de) Feste zusammensetzung
BR1101125A (pt) Imunoglobulina humanizada e composição farmacêutica
BR9605777A (pt) Composição farmacêutica
BR9505130A (pt) Composto e composiçao farmacêutica

Legal Events

Date Code Title Description
NB Patent issued - articles 230 and 231 of law 9279/96
B25D Requested change of name of applicant approved

Owner name: PDL BIOPHARMA, INC. (US)

Free format text: ALTERADO DE: PROTEIN DESING LABS, INC.

B25G Requested change of headquarter approved

Owner name: PDL BIOPHARMA, INC. (US)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020060191360/RJ DE 27/12/2006.